Kip Miriam Julia, Spies Claudia Doris, Neumann Tim, Nachbar Yvonne, Alling Christer, Aradottir Steina, Weinmann Wolfgang, Wurst Friedrich Martin
Department of Anesthesiology and Intensive Care Medicine, Charité-University Medicine Berlin, Berlin, Germany.
Alcohol Clin Exp Res. 2008 Jul;32(7):1284-91. doi: 10.1111/j.1530-0277.2008.00696.x.
A major part of medical pathology in internal medicine is associated with chronic alcoholism. The aim of the current study was to investigate whether screening for Alcohol Use Disorders (AUD) can be improved through determination of direct ethanol metabolites compared to traditional biological state markers, the Alcohol Use Disorders Identification Test (AUDIT) and additional self-reports beyond the detection time period of a positive blood alcohol concentration (BAC).
A total of 74 blood alcohol negative male patients who presented at the emergency room with either thoracic or gastrointestinal complaints were included. Phosphatidylethanol (PEth) was determined in whole blood, and ethyl glucuronide (EtG) in serum and urine samples. Traditional biological state markers [carbohydrate deficient transferrin (%CDT), gamma glutamyl transpeptidase (GGT), mean corpuscular volume (MCV)] were determined. The AUDIT was obtained and furthermore, all patients completed an additional self-report of alcohol consumption. Patients were divided into two (2) groups: AUDIT scores < 8 and AUDIT scores >or= 8.
After assessment of the AUDIT, patients were allocated to one of the following groups: patients with AUDIT scores < 8 (n = 52) and with AUDIT scores >or= 8 (n = 22). Twenty-five percent of the patients with AUDIT scores below the cut-off (n = 13/52) were tested positive for both PEth and UEtG. Of the patients who declared to be sober during the past 12 months, 38.5% were tested positive for PEth and UEtG. PEth discriminated similarly as %CDT for AUDIT scores >or= 8 (AUC: 0.672; 95%CI 0.524 to 0.821). Self-reports of alcohol consumption were unreliable.
Determination of direct ethanol metabolites such as PEth and UEtG provides additional evidence in screening for AUD in an ER setting. Determination of PEth might be considered complementary with or alternatively to %CDT.
内科医学中很大一部分病理情况与慢性酒精中毒有关。本研究的目的是调查与传统生物学状态标志物、酒精使用障碍识别测试(AUDIT)以及超出血液酒精浓度(BAC)阳性检测时间段的额外自我报告相比,通过测定直接乙醇代谢物是否能改善酒精使用障碍(AUD)的筛查。
纳入了74名因胸部或胃肠道不适到急诊室就诊的血液酒精阴性男性患者。测定全血中的磷脂酰乙醇(PEth)以及血清和尿液样本中的乙基葡萄糖醛酸苷(EtG)。测定传统生物学状态标志物[缺糖转铁蛋白(%CDT)、γ-谷氨酰转肽酶(GGT)、平均红细胞体积(MCV)]。获取AUDIT评分,此外,所有患者还完成了一份额外的饮酒自我报告。患者被分为两组:AUDIT评分<8分和AUDIT评分≥8分。
在评估AUDIT后,患者被分配到以下组之一:AUDIT评分<8分的患者(n = 52)和AUDIT评分≥8分的患者(n = 22)。AUDIT评分低于临界值的患者中有25%(n = 13/52)的PEth和尿EtG检测呈阳性。在过去12个月宣称戒酒的患者中,38.5%的PEth和尿EtG检测呈阳性。对于AUDIT评分≥8分的情况,PEth的鉴别能力与%CDT相似(曲线下面积:0.672;95%置信区间0.524至0.821)。饮酒自我报告不可靠。
测定直接乙醇代谢物如PEth和尿EtG为在急诊室环境中筛查AUD提供了额外证据。PEth的测定可被视为与%CDT互补或替代%CDT。